1[1]Vogt N, Bothner U, Brinkmann A, et al. Using 6% HES200/0.5 as the only colloid for treatment even of large blood loss is a safe and economic alternative to albumin. Anesthesia, 1999;54:121
2[2]Rehm M, Orth V, Scheigraber S, et al. Acid-base changes caused by 5%albumin versus 6% hydroxyethyl starch solution in patients undergoing acute normovolemic hemodilution. Anesthesiology,2000;93(5): 1174
3[4]Boldt J, Heesen M, Padberg W, et al. The influence of volume therapy and pentoxifylline infusion on circulating adhesion molecules in trauma patients Anaesthesia, 1996; 51:529
4[5]Dieterich HJ. Use of hydroxyethyl-starch in patients with renal insufficiency. Aneaesthesist, 1996;45:995
5[6]Kumle B, Boldt J, Piper S, et al. The influence of different intravascular volume replacement regimens on renal function in elderly. Anesth Analg, 1999;89(5): 1124
6[7]Vogt NH, Bothner U, Lerch G, et al. Large dose administration of 6% hydroxyethyl-starch 200/0.5 during total hip arthroplasty:plasma homeostasis, hemostasis and renal function compared to use 5% human albumin. Anesth Analg, 1996;83:262
7[8]Saito Y, Uchida K, Yamamoto H, et al. The maximum safe dosage of the low molecular weight hydroxyethyl starch, estimated from HES induced changes in coagulation parameters and clinical bleeding. Masui, 1999;48(3):238
8[9]Turkan H, Ural AU, Began C,et al. Effects ofhydroxyethyl starch on blood coagulation profile. Europ J Anaesth, 1999; 16:156
9[10]Jurecka W, Szepfalusi Z, Parth E, et al. Hydroxyethylstarch deposits in human skin-a model for pruritus? Arch Dermatol Res, 1993;285:13
